Glass House Brands (GLAS) Non Operating Income (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Non Operating Income of -$402000.0 for Q1 2026, up 64.11% quarter-over-quarter from -$1.1 million in Q4 2025.
Glass House Brands (GLAS) Non Operating Income (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Non Operating Income for 7 consecutive years, with -$402000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income changed N/A year-over-year to -$402000.0; the TTM figure through Mar 2026 stood at -$4.9 million (changed N/A YoY), while the FY2025 annual figure was -$485000.0, down 108.85% from the prior year.
- Non Operating Income improved to -$402000.0 in Q1 2026 per GLAS's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $22.9 million in Q2 2023 and bottomed at -$27.7 million in Q3 2022.
- Historically, Non Operating Income has averaged -$656662.4 across 5 years, with a median of -$761000.0 in 2025.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 981.11% — and 2023, when it jumped 600.94%.
- Glass House Brands' Non Operating Income stood at $4.8 million in 2022, then surged by 374.36% to $22.9 million in 2023, then tumbled by 122.72% to -$5.2 million in 2024, then jumped by 78.46% to -$1.1 million in 2025, then surged by 64.11% to -$402000.0 in 2026.
- Business Quant data shows GLAS's Non Operating Income at -$402000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$262000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Glass House Brands | 825.81 Mn | 807.26 Mn | 15.77 Mn | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -402,000.00 |
| Dec 31, 2025 | -1.12 Mn |
| Sep 30, 2025 | -262,000.00 |
| Jun 30, 2025 | -3.07 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Jun 30, 2023 | 22.88 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | -27.70 Mn |
| Jun 30, 2022 | -4.57 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 833,000.00 |
| Sep 30, 2021 | -2.56 Mn |
| Jun 30, 2021 | 1.24 Mn |
| Mar 31, 2021 | 6.42 Mn |
| Mar 31, 2020 | 398,811.00 |